We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
It could have saved thousands of dollars by taking the "slap on RFID and ship" route, but vitamin-maker Schiff thinks its full-blown RFID project will have a bigger payoff in the end.
In the pharma sector at least, the great RFID debate isn't about payback on the technology. It's about the merits of high-frequency vs. ultra-high-frequency tags.
Just as global businesses are becoming more insistent on better labor practices in their suppliers' plants, so, too, they may someday insist on doing business with companies that are working to improve their environmental practices.